Nanobodies: The Future of Antibody-Based Immune Therapeutics-Reference-Cited by-同舟云学术

Nanobodies: The Future of Antibody-Based Immune Therapeutics

Published:2021-03-01 Issue:2 Volume:36 Page:109-122
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Bathula Nuthan V.¹,Bommadevara Hemashree²,Hayes Jerrard M.¹

Affiliation:

1. School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

2. School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2020.3941

Reference161 articles.

1. Structural Studies of Immunoglobulins

2. Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions

3. Recombinant antibody constructs in cancer therapy

4. Antibody therapy of cancer

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and characterization of scFv-6009FV in Pichia pastoris with improved ability to neutralize the neurotoxin Cn2 from Centruroides noxius;International Journal of Biological Macromolecules;2024-08

2. Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review;Cancers;2024-07-27

3. Nanobody engineering: computational modelling and design for biomedical and therapeutic applications;FEBS Open Bio;2024-06-19

4. A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function;Biochemistry;2024-03-01

5. Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries;BMC Infectious Diseases;2024-02-13